Press Releases

Health News Posted on Friday, August 22, 2014

Press Releases »

Plastic Surgery: More Than Skin Deep, notes Dr. J

The reasons for plastic surgery are diverse and varied, and often go against expectations Plastic surgery procedures are still sometimes stigmatized in our society, as some judgmental onlookers have wrongly tended to dismiss such operations as ...

Read More

Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer

Research presented at the 29 th Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human papillomavirus, including the two that cause 70 percent of all cervical ...

Read More

Cornell''s X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging

Mark Riccio, director of Cornell University's multi-scale 3D computed tomography (CT) imaging facility, is using the online crowd-funding platform Kickstarter to bring non-invasive 3D, 4D and even 5D imaging to researchers and would-be superheros ...

Read More

Lincor Unveils Next Generation TV-based Patient Engagement Solution

 - MediaLINC unlocks the real value of Hospital TVs Today Lincor announced general availability of MediaLINC - its innovative Android-based Patient Engagement solution that delivers a range of education, entertainment and clinical content direct ...

Read More

Obesity Epidemic Answered with Healthy Revolutionary Ideas

Why do many weight-loss programs fail? Why are there so many contradicting weight-loss approaches presented in the media? From dietary nutritionists to fitness gurus, many have offered their insights and ideas of the best weight-loss program to ...

Read More

Mylan Launches First Generic Klor-Con® Extended-Release Tablets

Mylan Inc. (Nasdaq: MYL) today announced that it has launched Potassium Chloride Extended-release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg), which is the generic version of Upsher-Smith's Klor-Con®.  Mylan received final approval from the ...

Read More

Just Released - Cold Chain IQ Benchmarking Report: 7 Best Practice Case Studies

Taking a Peek Behind Closed Doors!   ColdChainIQ.com , a division of IQPC, is delighted to announce their brand new Benchmarking Report - a collection of some of the best case studies of leading pharmaceutical and biotech companies in the world. ...

Read More

Menzies Aviation Bobba Cargo Terminal Opens an Exclusive Pharma Cold Zone at Kempegowda International Airport, Bengaluru

Menzies Aviation Bobba, operating a cargo terminal at Kempegowda International Airport, Bengaluru, has opened an exclusive Pharma Cold Zone on 20th August for the handling of pharma products.      (Photo: ...

Read More

BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX ® (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX ® in the EU, today ...

Read More

Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses

Aptuit LLC announces that Aptuit SSCI, located in West Lafayette, Indiana , has enhanced its capabilities in the areas of structure determination and characterization of small and large molecules, including biologic drugs, metabolites, and ...

Read More

OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer

ENSPIRIT Trial to Continue as Planned Following Completion of the First of Two Interim Futility Analyses OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of ...

Read More

Bold Physician-Written Book Released by Stop the Thyroid Madness

"Stop the Thyroid Madness II: How Thyroid Experts are Challenging Ineffective Treatments and Improving the Lives of Patients" Stop the Thyroid Madness LLC (STTM) and author/editor Janie A. Bowthorpe , M.Ed, announce the release of the most ...

Read More

Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients

Twice-Weekly Prophylactic Regimen Resulted in 95% Reduction in Median Annualized Bleed Rate Compared to On-Demand Nektar Therapeutics (NASDAQ: NKTR) reports Baxter International Inc. today announced positive results from its Phase 3 pivotal ...

Read More

A new trial tests a combination of Vitamin C and "core" low dose, chemotherapy to reproduce promising safety and efficacy findings

Bruckner Oncology has initiated an FDA approved Phase II-III clinical trial which adds Vitamin C to chemotherapy "core" regimens (GFLIO and GFLIO-D)  for patients with locally advanced and metastatic pancreatic cancer (APC). Vitamin C was selected ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.